Issue link: https://www.e-digitaleditions.com/i/1511466
28 BioPharm International ® Manufacturing and Facilities eBook 2023 www.biopharminternational.com Nanoparticle (LNP) Delivery System Used in Man- ufacturing mRNA-Based Therapies. Oct. 5, 2023. 8. Novo Nordisk. New Cell Therapy Facilit y Enters Fight Against Chronic Diseases. Sept. 21, 2023. 9. Merck KGaA. MilliporeSigma to Become First Pro- v ider to Of fer Ful ly Integrated m RNA Ser v ices. Sept. 26, 2023. 10. ten23. ten23 health Expands Sterile Manufacturing Capacity at its VIVA 1® Facility through Completion of its First Expansion and the Introduction of an Additional Shift. Sept. 4, 2023. 11. FUJIFILM Diosynth. FUJIFILM Diosynth Biotech- nologies A n nounces New Da rl i ng ton, UK Vi ra l Vector Gene Therapy Facilit y is cGMP Ready for Manufacturing. Sept. 14, 2023. 12. Murphy, J. eXmoor pharma Expands into Full-Ser- vice Cell and Gene Therapy CDMO Par tner with Opening of GMP Facilities. BioPharmInternational. com, Oct. 12, 2023. 13. Wheeler Bio. Wheeler Bio Announces Grand Open- ing of Biomanufacturing Facility. Oct. 5, 2023. 14. Business Wire. Gr itgen T herapeut ics Launches Commercial GMP Facility in Suzhou, China. Oct. 10, 2023. 15. Biosynth. Biosynth Extends its Offering to Multi-Ki- logram GMP Peptide Synthesis through the Acqui- sition of Pepceuticals. Sept. 25, 2023. 16. Sharp. Sharp Acquires Berkshire Sterile Manufac- turing. Oct. 5, 2023. 17. Sterling. Sterling Pharma Solutions Acquires UK Contract Research Organisation, NewChem Tech- nologies. Oct. 13, 2023. ■ Curia ....................................................................................................................................................................................................................................................... 3 Entegris ................................................................................................................................................................................................................................................ 15 G-CON ................................................................................................................................................................................................................................................. 19 Grundfos ................................................................................................................................................................................................................................................ 5 LabVantage .........................................................................................................................................................................................................................................23 TriLink BioTechnologies ........................................................................................................................................................................................................................ 9 Ad Index COMPANY PAGE Industry update FOR MORE CONTENT e B O O K S E R I E S Single-Use Systems Oligonucleotides Tech Transfer Industry Update Sustainability N O V E M B E R 2 0 2 3 MANUFACTURING AND FACILITIES 2023 EMERGING THERAPIES 2023 EBOOK BioPharm International's Emerging Therapies 2023 eBook explores market trends, vaccine development, manufacturing of gene and cell therapies, and supply chain concerns. Topics discussed include plasmid DNA, ddPCR technology, and mRNA vaccines.